Receptor sorting through tubular microdomains of Rab7-positive endosomes in Charcot- Marie-Tooth disease 2B

通过 Charcot-Marie-Tooth 病 2B 中 Rab7 阳性内体的管状微结构域进行受体分选

基本信息

项目摘要

Charcot-Marie-Tooth (CMT) disease is an inherited neuropathy which affects the peripheral nervous system, leading to neurodegeneration. Disease onset occurs generally during adolescence or adulthood and is manifested by muscle weakness, loss of fine motor control and sensation in the extremities. In autosomal dominant Charcot-Marie Tooth type 2B (CMT2B), disease is caused by mutations in the late endosomal Rab7-GTPase. In neurons, Rab7- endosomes are important for the trafficking of growth-factors: Following activation by their respective ligand, growth-factor receptors are endocytosed, subsequently sorted into Rab7-positive endosomes and transported retrogradely to the soma where they regulate gene expression of pro-survival genes. Finally, receptors are degraded through the lysosomal pathway. Intriguingly, recent studies have linked CMT2B to impairments in trafficking of Rab7-positive late endosomes, but how mutations in Rab7-GTPase contribute to growth- factor receptors trafficking in CMT2B remains elusive. I hypothesize that endosomes in CMT2B-Rab7 mutants show perturbed sorting abilities due to disturbed formation of tubular microdomains into which receptors are routed during the sorting/trafficking process. Generally, it is considered that sorting occurs on early endosomes where receptors are sorted into the recycling pathways- either directly back to the plasma membrae or through the trans-golgi network (TGN). However, I hypothesize that these tubular microdomains on late endosomes also facilitate receptor sorting, potentially into lysosomes which would be a process uncoupled/in parallel from the process of endosomal maturation. The perturbation in forming such tubular microdomains could therefore affect sorting from Rab7-positive endosomes into lysosomes, defective receptor signalling, a delay in receptor degradation and ultimately downregulation of transcription genes which regulate innervation and/ or survival. All of these effects would explain several of the observed phenotypes in CMT2B, which includes prolonged growth-factor signaling, delay in growth factor sorting into lysosomes and defects in Rab7-endosome trafficking.The main goal of this project is to elucidate the pathogenic mechanisms leading to Charcot-Marie-Tooth type 2B, by focusing on mutations in Rab7-positive late endosomes within the endosomal sorting machinery. I will decipher interactions of Rab7-mutations in CMT2B with the cellular sorting machinery and I will follow subcellular localization of activated growth-factor receptors using high resolution imaging to visualize disturbed trafficking routes. I will address this in mouse DRG neurons as well as iPSC-derived motor- and sensory neurons from CMT2B patients. This proposed work will unravel sorting malfunctions in CMT2B and contribute to the evaluation of new therapeutic approaches by revealing possible target proteins.
腓骨肌萎缩症(CMT)是一种遗传性神经病,影响周围神经系统,导致神经变性。疾病发作通常发生在青春期或成年期,表现为肌肉无力、精细运动控制和四肢感觉丧失。在常染色体显性Charcot-Marie Tooth 2B型(CMT 2B)中,疾病是由晚期内体Rab 7-GT3突变引起的。在神经元中,Rab 7-内体对于生长因子的运输是重要的:在被它们各自的配体激活后,生长因子受体被内吞,随后被分选到Rab 7-阳性内体中,并逆行运输到索马,在那里它们调节促存活基因的基因表达。最后,受体通过溶酶体途径降解。有趣的是,最近的研究已经将CMT 2B与Rab 7阳性晚期内体运输的损伤联系起来,但是Rab 7-GT3中的突变如何有助于CMT 2B中的生长因子受体运输仍然是难以捉摸的。我假设CMT 2B-Rab 7突变体中的内体显示干扰的分选能力,这是由于在分选/运输过程中受体被路由到的管状微区的干扰形成。通常,认为分选发生在早期内体上,其中受体被分选到再循环途径中-直接回到质膜或通过trans-golgi网络(TGN)。然而,我假设晚期内体上的这些管状微结构域也促进受体分选,可能进入溶酶体,这将是与内体成熟过程解耦/平行的过程。因此,形成这种管状微结构域的扰动可能影响从Rab 7阳性内体到溶酶体的分选、缺陷的受体信号传导、受体降解的延迟以及调节神经支配和/或存活的转录基因的最终下调。 所有这些影响将解释几个观察到的表型CMT 2B,其中包括延长生长因子信号,延迟生长因子分选到溶酶体和Rab 7-内体trafficking.The主要目标的缺陷本项目的主要目标是阐明致病机制,导致Charcot-Marie-Tooth型2B,通过专注于突变Rab 7阳性内体内的内体分选机器。我将破译CMT 2B中Rab 7突变与细胞分选机制的相互作用,我将使用高分辨率成像来观察受干扰的贩运途径,从而跟踪活化的生长因子受体的亚细胞定位。我将在小鼠DRG神经元以及来自CMT 2B患者的iPSC衍生的运动和感觉神经元中解决这一问题。这项拟议的工作将解开CMT 2B中的分选故障,并通过揭示可能的靶蛋白来评估新的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr. Katja Burk, Ph.D.其他文献

Dr. Katja Burk, Ph.D.的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

货物受体Surf4介导SPARCL1在神经细胞中转运的分子机制研究
  • 批准号:
    32000488
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
SNX32在细胞囊泡运输中的功能研究
  • 批准号:
    32000487
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
非典型蛋白质胞吐外泌调控植物细胞极性产生和维系的时空作用规律和分子机制
  • 批准号:
    91954110
  • 批准年份:
    2019
  • 资助金额:
    68.0 万元
  • 项目类别:
    重大研究计划
小G蛋白Rab26调控胰岛素分泌及胰岛素分泌小体走向自噬降解途径的功能与机制研究
  • 批准号:
    31871423
  • 批准年份:
    2018
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
TBC1d23调节细胞器互作及突变引起脑桥小脑发育不全的机制研究
  • 批准号:
    91854121
  • 批准年份:
    2018
  • 资助金额:
    89.0 万元
  • 项目类别:
    重大研究计划
细胞分泌的调控及相关肠炎的机理研究
  • 批准号:
    31871429
  • 批准年份:
    2018
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目
表皮生长因子从反式高尔基网络运输到细胞膜的分子机制及表皮生长因子受体新靶点的探索
  • 批准号:
    31871421
  • 批准年份:
    2018
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Gαs参与调控早期内体分选的机制研究
  • 批准号:
    31701247
  • 批准年份:
    2017
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
植物ESCRT复合物组分蛋白的泛素化修饰及其调控膜蛋白转运和降解的分子机制研究
  • 批准号:
    31701246
  • 批准年份:
    2017
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
细胞内运输途径中两类蛋白重塑细胞膜的分子机制研究
  • 批准号:
    31670744
  • 批准年份:
    2016
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Characterizing molecular phenotypes of pancreatic islet reactive B cells in T1D through single cell sequencing
通过单细胞测序表征 T1D 中胰岛反应性 B 细胞的分子表型
  • 批准号:
    10600510
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Maturation of human humoral immunity through repeat malaria challenges
通过重复疟疾挑战使人体体液免疫成熟
  • 批准号:
    10720245
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Liver Pathobiology: insights through the lens of rare diseases
肝脏病理学:从罕见疾病的角度洞察
  • 批准号:
    10636874
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Directing Cytokine Specificity Through Co-translational Carrier Coupling
通过共翻译载体偶联指导细胞因子特异性
  • 批准号:
    10581947
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Enabling synthetic biology through single cell functional genomics
通过单细胞功能基因组学实现合成生物学
  • 批准号:
    10556421
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Lipoprotein Lipase Through the Secretory System
通过分泌系统的脂蛋白脂肪酶
  • 批准号:
    10586798
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Preventing Medication Mismanagement in People Living with Dementia through Automated Medication Dispensing with Facial Recognition and Video Observation
通过面部识别和视频观察自动配药,防止痴呆症患者用药管理不善
  • 批准号:
    10461514
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Explication of resistance to PD-1 blockade on nasopharyngeal car cinoma through the mechanism of protein sorting to exosomes
通过外泌体蛋白分选机制阐明鼻咽癌对PD-1阻断的抵抗力
  • 批准号:
    21K20946
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Targeting Health Disparities through Housing Redevelopment: A Natural Experiment of Housing Quality, Stability, and Economic Integration
通过住房重建消除健康差距:住房质量、稳定性和经济一体化的自然实验
  • 批准号:
    10458753
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Next generation mosquito control through technology-driven trap development and artificial intelligence guided detection of mosquito breeding habitats
通过技术驱动的诱捕器开发和人工智能引导的蚊子繁殖栖息地检测来控制下一代蚊子
  • 批准号:
    10490916
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了